您当前的位置：
首页 >
文章列表页 >
Mechanism of Yitangkang Prescription in Improving Metabolic-inflammatory Imbalance in Diabetic Kidney Disease by Cross-organ Regulation of Mast Cell Network
更新时间：2025-09-08

    • Mechanism of Yitangkang Prescription in Improving Metabolic-inflammatory Imbalance in Diabetic Kidney Disease by Cross-organ Regulation of Mast Cell Network

      增强出版
    • “According to the latest research, the traditional Chinese medicine compound Yitangkang can improve diabetes kidney disease by regulating mast cell degranulation, providing a new scheme for treatment.”
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 31, Issue 19, Pages: 277-287(2025)

    • DOI：10.13422/j.cnki.syfjx.20250917    

      CLC： R587.1;R285;R289

    • Received：28 June 2025，

      Revised：2025-08-04，

      Accepted：07 August 2025，

      Published Online：08 August 2025，

      Published：05 October 2025

    移动端阅览

  • ZHAO Mengdi,YU Jiaxiang,ZHANG Hanwen,et al.Mechanism of Yitangkang Prescription in Improving Metabolic-inflammatory Imbalance in Diabetic Kidney Disease by Cross-organ Regulation of Mast Cell Network[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(19):277-287. DOI： 10.13422/j.cnki.syfjx.20250917.

  •  
  •  

0

Views

40

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Mechanism of in Vitro and in vivo Models of Osteoporosis Regulation by Active Ingredients of Traditional Chinese Medicine： A Review
Bioinformatics Reveals Mechanism of Schisandrin B in Inhibiting Ferroptosis to Ameliorate Methionine and Choline Deficiency-induced Fatty Liver Disease in Mice
Protective Effect and Mechanism of Total Saponins of Codonopsis Radix on Cognitive Dysfunction in Aging Mice
Effect and Mechanism of Action of Epimedii Folium Polysaccharides on Mice with Exercise-induced Fatigue Based on p38 MAPK/NF-κB Signaling Pathway

Related Author

YANG Ming
WANG Jinji
ZHUANG Xuefeng
FANG Xiaolei
ZHU Zhijie
BAO Huiwei
LI Lijing
ZHU Zhifeng

Related Institution

School of Pharmaceutical Sciences，Changchun University of Chinese Medicine
Tonghua Golden-horse Group Co.Ltd.
Medical School of Nantong University
Yunnan University of Chinese Medicine
Nantong Hospital of Traditional Chinese Medicine
0